• AMG 487: CXCR3 Antagonist Workflow

  2026-09-18

  AMG 487 enables state-matched dissection of CXCR3 signaling across calcium flux, chemokine migration, macrophage polarization, and autophagy assays. This workflow combines potency-guided assay design with practical controls for solubility, vehicle effects, metabolism, and inflammatory-state interpretation.

• AICAR: Reliable AMPK Activation

  2026-09-17

  A practical, scenario-based guide to using AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside), SKU A8184, in cell viability, proliferation, and cytotoxicity workflows. It explains assay confounding, solution preparation, mechanistic controls, data interpretation, and evidence-based product selection.

• G-15 and GPR30: From Estrogen Signals to Pain Circuits

  2026-09-17

  G-15 is a selective G protein-coupled estrogen receptor antagonist that helps translational researchers separate GPR30-mediated signaling from classical estrogen receptor activity. This article connects its calcium and PI3K/Akt pharmacology with emerging evidence that spinal GPR30-positive neurons shape neuropathic pain, while outlining validation strategies, assay controls, and realistic translational boundaries.

• Anti-ROR1 Antibody: Applied Research Workflows

  2026-09-16

  Anti-ROR1 Antibody (Zilovertamab) supports a connected workflow from recombinant ROR1 binding and cell-surface profiling to Wnt5a pathway perturbation. Its strongest differentiation is the ability to pair quantitative ELISA and FACS validation with carefully controlled functional and translational studies.

• Busulfan Workflows for Senescence and Germ Cell Depletion

  2026-09-16

  Busulfan provides a practical DNA-damage tool for dose-responsive senescence studies in WI38 fibroblasts and injury-based germ-cell depletion models. When paired with dual-recombinase lineage tracing, it helps distinguish genuine cell regeneration from persistence or loss of pre-existing ovarian germ cells.

• NNC-55–0396, Calcium Signaling, and GBM Autophagy

  2026-09-15

  The reference study shows that NNC-55–0396 kills glioblastoma cells through a dual autophagy disturbance: it stimulates autophagy through ER calcium mobilization and IRE1α/JNK1 stress signaling while simultaneously impairing late-stage lysosomal degradation. This mechanistic framework links calcium-dependent stress responses, cytoplasmic vacuolation, lysosomal alkalinization, and cell death, providing useful guidance for designing pathway-resolved glioblastoma experiments.

• CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-09-15

  Gu et al. show that combining CDK4/6 inhibition with BET inhibition suppresses pancreatic ductal adenocarcinoma growth while counteracting the pro-invasive EMT response associated with palbociclib alone. Their data connect GSK3β-mediated Wnt/β-catenin activation with TGF-β/Smad pathway crosstalk, providing a mechanistic rationale for dual-pathway treatment design.

• Anlotinib Hydrochloride: From Target to Readout

  2026-09-14

  Anlotinib hydrochloride links VEGFR2, PDGFRβ, and FGFR1 inhibition to measurable angiogenic phenotypes. This article presents a mechanism-to-readout framework for cancer research, helping researchers distinguish endothelial effects from direct tumor-cell cytostasis and improve translational interpretation.

• GCG, Nucleocapsid Condensates, and SARS-CoV-2 Replication

  2026-09-14

  The reference study identifies RNA-triggered liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein as a functional process linked to viral replication. It further shows that the green-tea polyphenol GCG can disrupt N–RNA condensation and suppress viral replication, providing a mechanistic framework for studying antiviral compounds that target biomolecular condensates.

• Rotigotine Hydrochloride: Stability to Study Design

  2026-09-13

  Rotigotine hydrochloride is a dopamine D2/D3 receptor agonist with broad utility in Parkinson’s disease research and neurobiology. This guide connects receptor pharmacology with chiral purity, oxidation control, formulation choice, and assay design for more interpretable results.

• KN-62: From CaMKII Mechanism to Translation

  2026-09-12

  KN-62 offers a focused way to interrogate CaMKII within calcium-dependent biology. By connecting secretion, metabolism, cell-cycle phenotypes, and the Ca2+-autophagy findings reported in glioblastoma research, this article outlines a translational workflow that separates causal kinase effects from broader calcium perturbation.

• WY-14643 as a PPARα Benchmark for PFAS Studies

  2026-09-11

  WY-14643, also called Pirinixic Acid, provides a pharmacological benchmark for interpreting PPARα-dependent lipid disruption. This article connects its assay use with integrated zebrafish lipidomics and transcriptomics in PFHxS research, emphasizing controls, formulation, and mechanistic limits.

• Native protein gel electrophoresis: K4142 workflow

  2026-09-11

  Build a reproducible native-PAGE workflow for acidic proteins while preserving charge, conformation, complexes, and enzyme activity. The K4142 kit is especially useful when SDS-PAGE would erase the structural or functional signal needed for purification, identification, or mechanistic follow-up.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-09-10

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to the AXL receptor, with shorter fragments and selected tyrosine modifications showing especially strong effects. The work connects renin-angiotensin system peptide processing with viral receptor biology while emphasizing that binding results require validation in cellular and physiological models.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-09-10

  The reference study identifies the WNT5a/GSK3/β-catenin axis as a regulatory circuit that restrains adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors. By combining pharmacological perturbation, mass cytometry, transcriptomic integration, network modeling, and mouse injury models, it links pathway disruption with fatty degeneration and altered muscle regeneration.

8091 records 3/540 page Previous Next 12345 下5页 Last page